Inflammation as a Target for Epilepsy Therapy: The Case of Natalizumab

Saved in:
Bibliographic Details
Published inNeurology Vol. 97; no. 18; p. 845
Main Author Miller, John W
Format Journal Article
LanguageEnglish
Published United States 02.11.2021
Subjects
Epilepsy - drug therapy
Humans
Inflammation - drug therapy
Multiple Sclerosis - complications
Multiple Sclerosis - drug therapy
Natalizumab - adverse effects
Online AccessGet more information

Cover

Author Miller, John W
Author_xml – sequence: 1
  givenname: John W
  orcidid: 0000-0002-1632-1146
  surname: Miller
  fullname: Miller, John W
  email: millerjw@u.washington.edu
  organization: From the Department of Neurology, UW Regional Epilepsy Center, University of Washington, Seattle. millerjw@u.washington.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34521688$$D View this record in MEDLINE/PubMed
BookMark eNpFj8tKw0AYhQdR7EXfQGReIDVzn7iT0Goh1E1Ed-WfZH6N5EYmXcSnb0XFs_kOfHDgLMh527WekBsWrxhn_O51l63i_zButD0jc6a4jrTgbzOyCOHzJBQ3ySWZCak409bOyWbbYg1NA2PVtRQCBZrD8O5Hit1A131V-z5MNP_wA_TT_XehKQRPO6Q7GKGuvg4NuCtygVAHf_3LJXnZrPP0KcqeH7fpQxYVXOkxQisFuqJkifDoXSESXUowVsXCC0CTCGm0kWWpTh6MEchjXzhZOG1RYMyX5PZntz-4xpf7fqgaGKb93yF-BPBKTgY
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1212/WNL.0000000000012768
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
ExternalDocumentID 34521688
Genre Comment
Editorial
GroupedDBID ---
-~X
.XZ
.Z2
01R
0R~
123
1J1
29N
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAWTL
AAXQO
AAYEP
ABBLC
ABIVO
ABJNI
ABOCM
ABVCZ
ACDDN
ACGFS
ACILI
ACLDA
ACOAL
ACWRI
ACXJB
ADGGA
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFUWQ
AGINI
AHOMT
AHQNM
AHVBC
AIJEX
AKULP
AKWKN
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
E.X
EBS
ECM
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GQDEL
HZ~
IKYAY
IN~
IPNFZ
JF7
KD2
KMI
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHYEH
OJAPA
OL1
OLB
OLH
OLU
OLV
OLW
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RHI
RIG
RLZ
RXW
SJN
TEORI
TWZ
V2I
VVN
W3M
WH7
WOQ
WOW
XSW
XXN
XYM
XYN
YBU
YCJ
YFH
~9M
ID FETCH-LOGICAL-c256t-f843fbcd193efebc396d4a78503e3af79347674dd53efa773f20ecb4cb68f3f02
IngestDate Wed Oct 16 00:43:24 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 18
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c256t-f843fbcd193efebc396d4a78503e3af79347674dd53efa773f20ecb4cb68f3f02
ORCID 0000-0002-1632-1146
PMID 34521688
ParticipantIDs pubmed_primary_34521688
PublicationCentury 2000
PublicationDate 2021-11-02
PublicationDateYYYYMMDD 2021-11-02
PublicationDate_xml – month: 11
  year: 2021
  text: 2021-11-02
  day: 02
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurology
PublicationTitleAlternate Neurology
PublicationYear 2021
References 34521687 - Neurology. 2021 Nov 2;97(18):e1757-e1767
References_xml
SSID ssj0015279
Score 2.442412
SourceID pubmed
SourceType Index Database
StartPage 845
SubjectTerms Epilepsy - drug therapy
Humans
Inflammation - drug therapy
Multiple Sclerosis - complications
Multiple Sclerosis - drug therapy
Natalizumab - adverse effects
Title Inflammation as a Target for Epilepsy Therapy: The Case of Natalizumab
URI https://www.ncbi.nlm.nih.gov/pubmed/34521688
Volume 97
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3NS8MwFMCDHzB2Eb-_JQdvUk2bNMm8iTimaE8b7jaSNgEPbgXnQf96X5J2Kzph2kMpDYTwfs3r6-v7QOi8iIVRhpNISpVGLO2QSCnuyt0RS3JJmNDONfCU8d6APQzT4bzBos8umerL_HNhXsl_qMI94OqyZP9AdjYp3IBr4AtnIAznpRjfjy0ADcmHrmGMuuj7wG4fO3hXwoYv3z5cUIUrHFDHV9yq4L7PnOPm5fP9VemmheqrdTRd7fNswRBl0_QTJLFPmAuKzlS6LeERp757-Uz5heDYGrJsqDIZyjz-ULHwrgO5PGePofRjOOJEhO44DamXr17slIGFwOUSo98KX9dDq2hVSKe8MueIqX4QpYnoVJmQsKCrRctpo1Y9xbdvBm879DfRRmX045tAcAutmPE2aj1VYQ07qNsEidUbVjiAxAAS1yBxBfLaXWCHEU8sbmDcRYPuXf-2F1UNLqIcLM1pZCWjVucFGNHGGp3TDi-YEjIl1FBlQXUyV2upKFIYV0JQmxCTa5ZrLi21JNlDa-PJ2BwgzLRg3AibFNQwGRupLOw5SyiVTHKTHqL9IIFRGaqYjGrZHP06coza8wfpBK1b2DbmFGywqT7zNL4Ai6ssIA
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammation+as+a+Target+for+Epilepsy+Therapy%3A+The+Case+of+Natalizumab&rft.jtitle=Neurology&rft.au=Miller%2C+John+W&rft.date=2021-11-02&rft.eissn=1526-632X&rft.volume=97&rft.issue=18&rft.spage=845&rft_id=info:doi/10.1212%2FWNL.0000000000012768&rft_id=info%3Apmid%2F34521688&rft_id=info%3Apmid%2F34521688&rft.externalDocID=34521688